Company Monitoring Page for Novartis

latest headlines for company on cafepharma

FDA approves Novartis's multiple myeloma drug Farydak
Pharmaceutical Business Review
Wed, 02/25/15 - 10:01 am
Tags:
Novartis, Farydak, Multiple Myeloma
UK doctors lobby for off-label Avastin use
Medical Marketing and Media
Tue, 02/24/15 - 06:59 pm
Tags:
UK, Avastin, off-label, Lucentis, wet age-related macular degeneration, Roche, Novartis
FDA approves Novartis drug for bone marrow cancer
Yahoo/AP
Mon, 02/23/15 - 09:14 pm
Tags:
FDA, Novartis, Multiple Myeloma, Farydak
Novartis AG wins approval to buy GSK cancer drugs with conditions
Yahoo/Reuters
Mon, 02/23/15 - 06:00 pm
Tags:
Novartis, GSK, cancer, BRAF inhibitor, MEK inhibitor
Novartis leads a $28M round for rare disease biotech Merganser
Fierce Biotech
Thu, 02/19/15 - 09:59 am
Tags:
Novartis, Novartis Venture Fund, Merganser Biotech
Novartis makes concerted push into Israeli biotech startup scene
Fierce Biotech
Thu, 02/19/15 - 07:51 am
Tags:
Novartis, Israel, Gamida Cell, BioLineRx
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
Tags:
M&A, Actavis, Allergan, Forest Labs, GSK, Novartis, Bayer, Merck, Cubist Pharma, Roche, InterMune, Mylan Labs, Abbott Labs, Questcor, Mallinckrodt, Eli Lilly, Sun Pharma, Ranbaxy
Novartis seeks new Israeli technologies
Globes, Israel
Sun, 02/15/15 - 11:55 am
Tags:
Novartis
Glaxo Tries To Turn A Triple Play
Seeking Alpha
Wed, 02/11/15 - 09:11 am
Tags:
GSK, COPD, Chiesi, AstraZeneca, Novartis, Biogen Idec
New research: Could Novartis CVD game-changer increase dementia risk?
BioPharma Dive
Wed, 02/11/15 - 08:58 am
Tags:
Novartis, LCZ696
Ahead of Novartis deal, GlaxoSmithKline scoops up vaccine developer in $190M buyout
Fierce Biotech
Wed, 02/11/15 - 08:00 am
Tags:
GSK, Novartis, vaccines, M&A, GlycoVaxyn
Pharma Files Complaint Against Italy for Reimbursing Off-Label Prescribing
WSJ Pharmalot
Tue, 02/10/15 - 06:40 pm
Tags:
Italy, off-label, Avastin, Lucentis, Roche, Novartis
Amgen, Inc. Files Petition To Stop Novartis (NVS) From Launching Neupogen Bilosimilar
Bidness Etc.
Tue, 02/10/15 - 08:38 am
Tags:
Amgen, Novartis, Neupogen, biosimilars
New Heart Drug From Novartis: Will It Raise The Risk of Alzheimer's Disease?
Forbes
Mon, 02/9/15 - 10:39 am
Tags:
Novartis, Alzheimer's disease, LCZ696
AstraZeneca plc Beefs Up Precision Medicine Arsenal
Motley Fool
Mon, 02/9/15 - 08:20 am
Tags:
AstraZeneca, Novartis, Thermo Fisher, precision medicine
Novartis says Japanese health ministry to suspend unit
Yahoo/Reuters
Tue, 02/3/15 - 09:14 am
Tags:
Novartis, Japan
Novartis Wins FDA Approval For Ocular Allergy Solution, Pazeo (TM)
Bidness Etc.
Mon, 02/2/15 - 05:48 pm
Tags:
Novartis, FDA, ocular allergies, Alcon, Pazeo
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Tags:
Ophthotech, Novartis, Regeneron, Fovista, Roche, Avastin, Eylea, Lucentis, wet age-related macular degeneration
Stocks That Battle Cancer Were The Best-Performing Biotechs In January
Yahoo/Benzinga
Fri, 01/30/15 - 02:34 pm
Tags:
Novartis, Celgene, Pharmacyclics, EXACT Sciences, Tesaro, Foundation Medicine, Bind Therapeutics, Kite Pharma, Celldex Therapeutics
The $25B GSK-Novartis deal clears major hurdle
Bizjournals.com
Wed, 01/28/15 - 04:33 pm
Tags:
GSK, Novartis, Eli Lilly, vaccines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.